St. Louis, MO
Home ► Blog ► FDA & Prescription Drugs
The FDA released a public safety alert, warning type 2 diabetes patients taking SGLT-2 inhibitors that they may be at risk of developing necrotizing fasciitis of the genitals and genital area. Necrotizing fasciitis of the genital area, also called Fo Read More »
According to a study published in the American Journal of Physiology, the chemical flavorings and additives in e-cigarettes can potentially cause more damage to the lungs than damage caused by conventional cigarettes. The study, which was conducted b Read More »
“Juuling.” A new trend, and not a good one, has taken the world by storm, seen on sidewalks and school campuses around the country. But, what is it, why are our children using them, and what are the Juuling dangers? Juul is a popular USB-styled e Read More »
( July 12, 2018 )– A Missouri state court has come to a decision on a claim that Johnson & Johnson cosmetic talc products, supposedly containing asbestos, caused 22 women to develop ovarian cancer. The jury of 12 ruled unanimously in favor of t Read More »
Big Pharma’s monopoly over the generic drugs industry has for years been cause for concern for U.S. hospital systems, which frequently deal with drug scarcity and manipulation of drug prices brought on by the pharmaceutical industry. Now, some Read More »
How is it possible that 2017 went by so quickly? Before we embark on our tasks for the new year, we want to review what occurred over the past 12 months as 2017 was an incredibly busy time period in the world of personal injury law. While we’v Read More »
Next up on the THL People Series is Kristie Stephens. Kristie has been working with most of the attorneys for a while now, even before we opened the doors to THL. Throughout her nearly decade-long career with the firm, she has remained a key part of Read More »
(December 11, 2017) — The 9th Circuit U.S. Court of Appeals decided on Wednesday to reverse the dismissal of all incretin cases involved in incretin lawsuit MDL 2452, which had been previously dismissed by the Southern District of California tr Read More »
(October 2, 2017) — Today, the U.S. Supreme Court allowed to stand an appellate court decision stating that a product manufacturer is subject to personal jurisdiction for product-related claims in a state where development or testing occurred, Read More »
Contact us by phone at 1-888-508-6752 or email us below.
© 2017 TorHoerman Law LLC.
The contents of this webpage have been prepared by TorHoerman Law, LLC for informational purposes only. None of this information is intended as either legal or medical advice or opinions. No attorney/client relationship is established with use of this website. Sending or receiving information through this site, posting to our blogs/news site does not establish an attorney/client relationship. An attorney/client relationship with TorHoerman Law is established only by an express and written agreement by TorHoerman Law to represent you. Our attorneys make a case-by-case assessment of any claims and results may vary depending on the facts concerning any case. The attorneys at TorHoerman Law are licensed to practice in Illinois, Missouri, and California. In some circumstances, cases may be sent to other qualified lawyers. In those circumstances, TorHoerman Law maintains joint responsibility.
Wesite Design & Development by Kaizen Coding